Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Impact of a physiologic definition on bronchopulmonary dysplasia rates.

Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, Auten K, Newman N, Rowan G, Grisby C, Arnell K, Miller L, Ball B, McDavid G; National Institute of Child Health and Human Development Neonatal Research Network.

Pediatrics. 2004 Nov;114(5):1305-11.

PMID:
15520112
2.

Definitions and diagnostic criteria for bronchopulmonary dysplasia.

Bancalari E, Claure N.

Semin Perinatol. 2006 Aug;30(4):164-70. Review.

PMID:
16860155
3.

Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition.

Bancalari E, Claure N, Sosenko IR.

Semin Neonatol. 2003 Feb;8(1):63-71. Review.

PMID:
12667831
4.

Pulmonary outcomes in bronchopulmonary dysplasia.

Bhandari A, Panitch HB.

Semin Perinatol. 2006 Aug;30(4):219-26. Review.

PMID:
16860162
5.

The 'new' bronchopulmonary dysplasia: challenges and commentary.

Merritt TA, Deming DD, Boynton BR.

Semin Fetal Neonatal Med. 2009 Dec;14(6):345-57. doi: 10.1016/j.siny.2009.08.009. Epub 2009 Sep 10. Review.

PMID:
19747889
6.

Management of infants with bronchopulmonary dysplasia in Germany.

Thomas W, Speer CP.

Early Hum Dev. 2005 Feb;81(2):155-63. Epub 2005 Jan 18. Review.

PMID:
15748970
7.

Lung function outcome in children of premature birth.

Kennedy JD.

J Paediatr Child Health. 1999 Dec;35(6):516-21. Review.

PMID:
10634975
8.
9.

Definition and outpatient management of the very low-birth-weight infant with bronchopulmonary dysplasia.

Groothuis JR, Makari D.

Adv Ther. 2012 Apr;29(4):297-311. doi: 10.1007/s12325-012-0015-y. Epub 2012 Apr 16. Review.

PMID:
22529025
10.

Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants.

O'Shea JE, Davis PG, Doyle LW; Victorian Infant Collaborative Study Group.

Pediatr Res. 2012 Feb;71(2):210-4. doi: 10.1038/pr.2011.27. Epub 2011 Dec 21. Review.

PMID:
22258134
11.

Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.

Schmidt B, Roberts R, Millar D, Kirpalani H.

Neonatology. 2008;93(4):284-7. doi: 10.1159/000121453. Epub 2008 Jun 5. Review.

PMID:
18525211
12.

[Bronhopulmonary dysplasia].

Farstad T, Bratlid D.

Tidsskr Nor Laegeforen. 2007 Sep 20;127(18):2374-7. Review. Norwegian.

13.

Is there a role for antioxidant therapy in bronchopulmonary dysplasia?

Welty SE.

J Nutr. 2001 Mar;131(3):947S-950S. Review.

14.

Current therapy of bronchopulmonary dysplasia.

Rush MG, Hazinski TA.

Clin Perinatol. 1992 Sep;19(3):563-90. Review.

PMID:
1526072
15.

Epidemiology of bronchopulmonary dysplasia.

Van Marter LJ.

Semin Fetal Neonatal Med. 2009 Dec;14(6):358-66. doi: 10.1016/j.siny.2009.08.007. Epub 2009 Sep 26. Review.

PMID:
19783238
16.

Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies.

Saugstad OD, Aune D.

Neonatology. 2014;105(1):55-63. doi: 10.1159/000356561. Epub 2013 Nov 15. Review.

17.

[Premature infants bronchopulmonary dysplasia: past and present].

Hadchouel A, Delacourt C.

Rev Pneumol Clin. 2013 Aug;69(4):207-16. doi: 10.1016/j.pneumo.2013.05.003. Epub 2013 Jul 15. Review. French.

PMID:
23867575
18.

Oxygen toxicity in premature infants.

Weinberger B, Laskin DL, Heck DE, Laskin JD.

Toxicol Appl Pharmacol. 2002 May 15;181(1):60-7. Review.

PMID:
12030843
19.

The new bronchopulmonary dysplasia.

Jobe AH.

Curr Opin Pediatr. 2011 Apr;23(2):167-72. doi: 10.1097/MOP.0b013e3283423e6b. Review.

20.

Advances in bronchopulmonary dysplasia.

Strueby L, Th├ębaud B.

Expert Rev Respir Med. 2014 Jun;8(3):327-38. doi: 10.1586/17476348.2014.899907. Epub 2014 Mar 26. Review.

PMID:
24666156

Supplemental Content

Support Center